Fibrinolytic and Inflammatory Markers for Arterial Occlusion: The Evolving Epidemiology of Thrombosis and Hemostasis

This publication has 49 references indexed in Scilit:

• Alu-repeat polymorphism in the tissue-type plasminogen activator (t-PA) gene, t-PA levels and risk of familial myocardial infarction (MI)
  Fibrinolysis, 1996
• 89. Polymorphism of the blood clot lysis enzyme tissue-type plasminogen activator is associated with myocardial infarction
  Fibrinolysis, 1996
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.
  Proceedings of the National Academy of Sciences, 1995
• Prospective study of endogenous tissue plasminogen activator and risk of stroke
  The Lancet, 1994
• A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
  The Lancet, 1993
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction
  The Lancet, 1993
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
  Metabolism, 1986